|
|
|
|
Biovision has rights to numerous patents related to biomaterials, biomimetic surfaces, manufacturing processes, optical designs and other technologies. The patent portfolio is shared by BioGel Group. Biovision has exclusive rights to these technologies for use in ophthalmology in general and ophthalmic implants in particular. These rights are exclusive worldwide except the Exclusive Territory of GEL-MED International. For our portfolio of patents, see list of Patents. designed and constructed by stehno [stehnisko@seznam.cz] |